These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15317896)

  • 1. The safety and availability of blood and tissues--progress and challenges.
    Goodman JL
    N Engl J Med; 2004 Aug; 351(8):819-22. PubMed ID: 15317896
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 and HCV infections among antibody-negative blood donors.
    Kainer MA; Jarvis WR
    N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559958
    [No Abstract]   [Full Text] [Related]  

  • 3. Status of NAT screening for HCV, HIV and HBV--experiences of the German Red Cross Blood Donation Services.
    Seifried E; Findhammer S; Roth WK
    Dev Biol (Basel); 2002; 108():23-7. PubMed ID: 12220139
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood safety and nucleic acid testing in Europe.
    Laperche S
    Euro Surveill; 2005 Feb; 10(2):3-4. PubMed ID: 15735316
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of multiplex NAT in blood screening.
    Candotti D; Allain JP
    Dev Biol (Basel); 2007; 127():71-86. PubMed ID: 17486882
    [No Abstract]   [Full Text] [Related]  

  • 8. Chiron's procleix HIV-1/HCV assay receives FDA approval.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):94. PubMed ID: 11962342
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
    Busch MP; Caglioti S; Robertson EF; McAuley JD; Tobler LH; Kamel H; Linnen JM; Shyamala V; Tomasulo P; Kleinman SH
    N Engl J Med; 2005 Aug; 353(5):460-7. PubMed ID: 16079369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of West Nile virus through blood transfusion in the United States in 2002.
    Pealer LN; Marfin AA; Petersen LR; Lanciotti RS; Page PL; Stramer SL; Stobierski MG; Signs K; Newman B; Kapoor H; Goodman JL; Chamberland ME;
    N Engl J Med; 2003 Sep; 349(13):1236-45. PubMed ID: 14500806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(13):281-4. PubMed ID: 15071426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of viremia in early hepatitis C virus infection.
    Glynn SA; Wright DJ; Kleinman SH; Hirschkorn D; Tu Y; Heldebrant C; Smith R; Giachetti C; Gallarda J; Busch MP
    Transfusion; 2005 Jun; 45(6):994-1002. PubMed ID: 15934999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verses, viruses, and the vulnerability of the blood supply in industrialized countries.
    Mushahwar IK
    J Med Virol; 2007 Aug; 79(8):1229-37. PubMed ID: 17596828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood safety--at what cost?
    Bekker LG; Wood R
    JAMA; 2006 Feb; 295(5):557-8. PubMed ID: 16449622
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV-1 and HCV infections among antibody-negative blood donors.
    Prince AM
    N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559960
    [No Abstract]   [Full Text] [Related]  

  • 16. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093
    [No Abstract]   [Full Text] [Related]  

  • 18. Predonation testing of potential blood donors in resource-restricted settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Candotti D; Allain JP
    Transfusion; 2005 Sep; 45(9):1542-3. PubMed ID: 16131391
    [No Abstract]   [Full Text] [Related]  

  • 19. Predonation testing of potential blood donors in resource-restricted settings.
    Gorlin JB
    Transfusion; 2005 Sep; 45(9):1541-2. PubMed ID: 16131390
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.